Pit J Voss1, Martin J Stoddart2, Anke Bernstein3, Rainer Schmelzeisen4, Katja Nelson5, Vincent Stadelmann6, Thomas Ziebart7, Philipp J Poxleitner8,9. 1. Department of Oral and Maxillofacial Surgery, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. pit.voss@uniklinik-freiburg.de. 2. AO Research Institute Davos, Clavadelerstr. 8, 7270, Davos, Switzerland. martin.stoddart@aofoundation.org. 3. Department of Orthopedics and Traumatology, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. anke.bernstein@uniklinik-freiburg.de. 4. Department of Oral and Maxillofacial Surgery, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. rainer.schmelzeisen@uniklinik-freiburg.de. 5. Department of Oral and Maxillofacial Surgery, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. katja.nelson@uniklinik-freiburg.de. 6. AO Research Institute Davos, Clavadelerstr. 8, 7270, Davos, Switzerland. vincent.stadelmann@aofoundation.org. 7. Department of Oral and Maxillofacial Surgery, University Hospital Mainz, Augustusplatz 2, 55131, Mainz, Germany. ziebart@mkg.klinik.uni-mainz.de. 8. Department of Oral and Maxillofacial Surgery, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. philipp.poxleitner@uniklinik-freiburg.de. 9. AO Research Institute Davos, Clavadelerstr. 8, 7270, Davos, Switzerland. philipp.poxleitner@uniklinik-freiburg.de.
Abstract
OBJECTIVES: Bisphosphonate-related osteonecrosis of the jaw (BP-ONJ) occurs in 1 % of patients with medication-induced osteoporosis treated with bisphosphonates. Sheep are an established large animal model for investigating osteoporotic skeletal changes. Zoledronate significantly reduces tissue mineral variability in ovariectomized sheep. The aim of this study was to analyze bone healing after tooth extraction in sheep with induced osteopenia and zoledronate administration. MATERIALS AND METHODS: Eight adult ewes were randomly divided into two groups of four animals. All sheep underwent ovariectomy and a low-calcium diet. Dexamethasone was administered weekly for 16 weeks. Zoledronate was then given every third week for a further 16 weeks in four sheep; these infusions were repeated after extraction of two lower premolars. Four sheep without zoledronate administrations served as controls. RESULTS: Due to general health conditions, two sheep of the zoledronate group had to be excluded before surgery. The remaining two sheep of this group developed BP-ONJ lesions at the extraction site and various other sites in both jaws. Control group animals showed uneventful wound healing. Histology of the alveolar processes as well as lumbar spine revealed larger portions of old bone and smaller portions of new bone in the zoledronate group. CONCLUSIONS: This animal study showed uneventful wound healing after tooth extraction in osteopenic sheep whereas zoledronate treatment leads to development of BP-ONJ-like lesions. CLINICAL RELEVANCE: As bisphosphonate administration is a standard treatment for glucocorticoid-induced osteoporosis, this model can be used for further research in pathogenesis and management of bisphosphonate-related adverse events.
OBJECTIVES:Bisphosphonate-related osteonecrosis of the jaw (BP-ONJ) occurs in 1 % of patients with medication-induced osteoporosis treated with bisphosphonates. Sheep are an established large animal model for investigating osteoporotic skeletal changes. Zoledronate significantly reduces tissue mineral variability in ovariectomized sheep. The aim of this study was to analyze bone healing after tooth extraction in sheep with induced osteopenia and zoledronate administration. MATERIALS AND METHODS: Eight adult ewes were randomly divided into two groups of four animals. All sheep underwent ovariectomy and a low-calcium diet. Dexamethasone was administered weekly for 16 weeks. Zoledronate was then given every third week for a further 16 weeks in four sheep; these infusions were repeated after extraction of two lower premolars. Four sheep without zoledronate administrations served as controls. RESULTS: Due to general health conditions, two sheep of the zoledronate group had to be excluded before surgery. The remaining two sheep of this group developed BP-ONJ lesions at the extraction site and various other sites in both jaws. Control group animals showed uneventful wound healing. Histology of the alveolar processes as well as lumbar spine revealed larger portions of old bone and smaller portions of new bone in the zoledronate group. CONCLUSIONS: This animal study showed uneventful wound healing after tooth extraction in osteopenic sheep whereas zoledronate treatment leads to development of BP-ONJ-like lesions. CLINICAL RELEVANCE: As bisphosphonate administration is a standard treatment for glucocorticoid-induced osteoporosis, this model can be used for further research in pathogenesis and management of bisphosphonate-related adverse events.
Entities:
Keywords:
Bisphosphonates; Large animal study; Oral and maxillofacial surgery; Oral pathology; Osteoporosis; Ovariectomy; Wound healing
Authors: Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra Journal: J Oral Maxillofac Surg Date: 2009-05 Impact factor: 1.895
Authors: C C Glüer; K E Scholz-Ahrens; A Helfenstein; G Delling; W Timm; Y Açil; R Barkmann; J Hassenpflug; B Stampa; F Bauss; J Schrezenmeir Journal: Bone Date: 2006-12-15 Impact factor: 4.398
Authors: Babul Borah; Thomas E Dufresne; Paula A Chmielewski; Gary J Gross; Marla C Prenger; Roger J Phipps Journal: J Bone Miner Res Date: 2002-07 Impact factor: 6.741
Authors: Stephen T Sonis; Brynmor A Watkins; Gregory D Lyng; Mark A Lerman; Kenneth C Anderson Journal: Oral Oncol Date: 2008-08-19 Impact factor: 5.337
Authors: Michael Krimmel; Jana Ripperger; Martin Hairass; Sebastian Hoefert; Susanne Kluba; Siegmar Reinert Journal: Oral Maxillofac Surg Date: 2013-03-20
Authors: Christoph Pautke; Kilian Kreutzer; Jochen Weitz; Martina Knödler; Daniela Münzel; Gabriele Wexel; Sven Otto; Alexander Hapfelmeier; Stephen Stürzenbaum; Thomas Tischer Journal: Bone Date: 2012-05-07 Impact factor: 4.398
Authors: A M Pabst; M Krüger; K Sagheb; T Ziebart; C Jacobs; S Blatt; E Goetze; C Walter Journal: Clin Oral Investig Date: 2016-05-12 Impact factor: 3.573
Authors: Henrik Holtmann; Julian Lommen; Norbert R Kübler; Christoph Sproll; Majeed Rana; Patrick Karschuck; Rita Depprich Journal: J Int Med Res Date: 2018-08-09 Impact factor: 1.671